Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorBeijing University of Chinese Medicine
About this trial
Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG malignant transformation events combining TCM indicators with modern medicine indicators. The proposed study is a registry study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 study patients diagnosed with CAG will be recruited. 10-year follow-ups are carried out on-site in hospitals and off-site by telephone to track malignant transformation events.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
No treatment groups listed
Sponsors and collaborators
Beijing University of Chinese Medicine
Lead sponsor
The University of Science and Technology of China
Collaborator
China Academy of Chinese Medical Sciences
Collaborator
Harvard Medical School (HMS and HSDM)
Collaborator
Source ClinicalTrials.gov